BTX

BlackRock Technology and Private Equity Term Trust (BTX)

US
$ 6.2412.64%

Price Chart

Key Statistics

Market Cap
$ 1.34B
P/E Ratio
36.94
Revenue (TTM)
$ 0
Volume
787.25K
52W High
$ 8.00
52W Low
$ 5.15
Dividend Yield
0.00%
Beta
0.00

Technicals

50-Day MA
6.596
200-Day MA
7.3487
52 Week High
7.9984
52 Week Low
5.146

About BTX

Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer.

Employees
10
Headquarters
San Diego, CA
CEO
Dr. Roger Sidhu M.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg